Monte Rosa Therapeutics, Inc. Ratios

Ratios Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -92.74%
EBIT Margin -107.26%
EBITDA Margin -96.97%
Operating Margin -107.26%
Net Margin -96.18%
FCF Margin 50.26%
Efficiency
Assets Average 371.24M
Equity Average 201.09M
Invested Capital 179.25M222.94M
Asset Utilization Ratio 0.20
Leverage & Solvency
Equity Ratio 0.590.51
Valuation
Enterprise Value 949.65M368.32M46.54M45.41M
Market Capitalization 949.65M368.32M282.96M426.37M
Return Ratios
Return on Sales -0.96%
Return on Capital Employed -0.38%
Return on Assets -0.20%
Return on Equity -0.36%